HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoko Orii Selected Research

CD5 Antigens

11/2021Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development.
1/2021IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoko Orii Research Topics

Disease

2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2021 - 01/2021
2Infections
01/2018 - 01/2018
1Neoplasms (Cancer)
01/2018
1Communicable Diseases (Infectious Diseases)
01/2018

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
11/2021 - 01/2018
2CD5 AntigensIBA
11/2021 - 01/2021
2Interleukin-23 Subunit p19IBA
11/2021 - 01/2021
2Interleukin-27 (Interleukin 27)IBA
01/2018 - 01/2018
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2021
1Macrophage Colony-Stimulating FactorIBA
01/2018
1InterferonsIBA
01/2018
1Interleukin-1 (Interleukin 1)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2018